Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study

被引:160
作者
Khalili, Hamed [1 ]
Huang, Edward S. [1 ]
Jacobson, Brian C. [2 ]
Camargo, Carlos A., Jr. [3 ,4 ,5 ]
Feskanich, Diane [4 ,5 ]
Chan, Andrew T. [1 ,4 ,5 ]
机构
[1] Massachusetts Gen Hosp, Gastroenterol Unit, Boston, MA 02114 USA
[2] Boston Univ, Med Ctr, Sect Gastroenterol, Boston, MA 02118 USA
[3] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA
[4] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA
[5] Harvard Univ, Sch Med, Boston, MA USA
来源
BRITISH MEDICAL JOURNAL | 2012年 / 344卷
基金
美国国家卫生研究院;
关键词
INTESTINAL CALCIUM-ABSORPTION; FOOD FREQUENCY QUESTIONNAIRE; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; REPRODUCIBILITY; OMEPRAZOLE; MORTALITY; VALIDITY; SMOKING; METAANALYSIS;
D O I
10.1136/bmj.e372
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To examine the association between chronic use of proton pump inhibitors (PPIs) and risk of hip fracture. Design Prospective cohort study. Setting Nurses' Health Study, which originally recruited from the 11 most populous states in the US. Participants 79 899 postmenopausal women enrolled in the Nurses' Health Study who provided data on the use of PPIs and other risk factors biennially since 2000 and were followed up to 1 June 2008. Main outcome measure Incident hip fracture Results During 565 786 person years of follow-up, we documented 893 incident hip fractures. The absolute risk of hip fracture among regular users of PPIs was 2.02 events per 1000 person years, compared with 1.51 events per 1000 person years among non-users. Compared with non-users, the risk of hip fracture among women who regularly used PPIs for at least two years was 35% higher (age adjusted hazard ratio 1.35 (95% confidence interval 1.13 to 1.62)), with longer use associated with increasing risk (P-trend<0.01). Adjustment for risk factors, including body mass index, physical activity, and intake of calcium did not materially alter this association (hazard ratio 1.36 (1.13 to 1.63)). These associations were also not changed after accounting for reasons for PPI use. The relation between PPI use and fracture differed by smoking history (P-interaction=0.03). Among current and former smokers, PPI use was associated with greater than 50% increase in risk of fracture, with a multivariate hazard ratio for fracture of 1.51 (1.20 to 1.91). In contrast, among women who never smoked there was no association (multivariate hazard ratio 1.06 (0.77 to 1.46)). In a meta-analysis of these results with 10 prior studies, the pooled odds ratio of hip fracture associated with PPI use was 1.30 (1.25 to 1.36). Conclusion Chronic use of PPIs is associated with increased risk of hip fracture, particularly among women with a history of smoking.
引用
收藏
页数:13
相关论文
共 43 条
[21]   Body-mass index and symptoms of gastroesophageal reflux in women [J].
Jacobson, Brian C. ;
Somers, Samuel C. ;
Fuchs, Charles S. ;
Kelly, Ciaran P. ;
Camargo, Carlos A., Jr. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (22) :2340-U18
[22]   Proton pump inhibitor use and risk of hip fractures in patients without major risk factors [J].
Kaye, James A. ;
Jick, Hershel .
PHARMACOTHERAPY, 2008, 28 (08) :951-959
[23]   Smoking increases bone loss and decreases intestinal calcium absorption [J].
Krall, EA ;
Dawson-Hughes, B .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (02) :215-220
[24]   Meta-analysis: Risk of fractures with acid-suppressing medication [J].
Kwok, Chun Shing ;
Yeong, Jessica Ka-Yan ;
Loke, Yoon Kong .
BONE, 2011, 48 (04) :768-776
[25]   Mortality, disability, and nursing home use for persons with and without hip fracture: A population-based study [J].
Leibson, CL ;
Tosteson, ANA ;
Gabriel, SE ;
Ransom, JE ;
Melton, LJ .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (10) :1644-1650
[26]   Cigarette smoke extract inhibits chemotaxis and collagen gel contraction mediated by human bone marrow osteoprogenitor cells and osteoblast-like cells [J].
Liu, XD ;
Kohyama, T ;
Kobayashi, T ;
Abe, S ;
Kim, HJ ;
Reed, EC ;
Rennard, SI .
OSTEOPOROSIS INTERNATIONAL, 2003, 14 (03) :235-242
[27]   EFFECT OF OMEPRAZOLE, AN INHIBITOR OF H+, K+-ATPASE, ON BONE-RESORPTION IN HUMANS [J].
MIZUNASHI, K ;
FURUKAWA, Y ;
KATANO, K ;
ABE, K .
CALCIFIED TISSUE INTERNATIONAL, 1993, 53 (01) :21-25
[28]   Proton Pump Inhibitors and Risk of Fracture: A Systematic Review and Meta-Analysis of Observational Studies [J].
Ngamruengphong, Saowanee ;
Leontiadis, Grigorios I. ;
Radhi, Saba ;
Dentino, Andrew ;
Nugent, Kenneth .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (07) :1209-1218
[29]   Effects of proton pump inhibitors on calcium carbonate absorption in women: A randomized crossover trial [J].
O'Connell, MB ;
Madden, DM ;
Murray, AM ;
Heaney, RP ;
Kerzner, LJ .
AMERICAN JOURNAL OF MEDICINE, 2005, 118 (07) :778-781
[30]   Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study [J].
Pouwels, S. ;
Lalmohamed, A. ;
Souverein, P. ;
Cooper, C. ;
Veldt, B. J. ;
Leufkens, H. G. ;
de Boer, A. ;
van Staa, T. ;
de Vries, F. .
OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) :903-910